Tarsons Products Limited has submitted to the Exchange, the financial results for the period ended March 31, 2025.
TARSONS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 7.1 pts less than Nifty Microcap 250 and 6.1 pts less than its Medical Equipment & Supplies peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Tarsons Products Limited has submitted its financial results to the Exchange for the period ending March 31, 2025. This is a routine regulatory filing indicating the company has reported its full-year and/or fourth-quarter numbers. No specific financial figures, growth rates, or detailed commentary were provided in the filing headline. Investors will need to review the full results document to understand the company's performance for the period.
This is a standard compliance filing — no immediate price action expected solely from the submission itself. Shareholders should review the detailed results (revenue, profit, margins, and management commentary) for actual performance insights.